SAALI Biotechnologies Aps: Financial statements 2024
CVR: 38619292
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
SAALI Biotechnologies Aps (CVR 38619292) has filed annual accounts for 2024. In 2024, the company reported a net result of DKK -1,237 compared with DKK -1,109 the year before. Equity in the 2024 report amounted to DKK -11,866.
- Profit/Loss
- DKK -1,237
- Equity
- DKK -11,866
- Total Assets
- DKK 0
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | -1K | -12K | 0 |
| 2023 | 0 | 0 | -1K | -12K | 0 |
| 2022 | - | - | -2K | -11K | 0 |
| 2021 | 0 | 0 | -44K | -10K | 0 |
| 2020 | 0 | 0 | 0 | -10K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
SAALI Biotechnologies Aps has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -1,109.
About SAALI Biotechnologies Aps
SAALI Biotechnologies Aps is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2017. The company is registered under the industry Anden forarbejdning og konservering af frugt og grøntsager. The management consists of Sander Sieuwerts and Lina Nadirova. The company is owned by Sander Sieuwerts and Lina Nadirova. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,348 compared with DKK -1,237 the year before. Equity in the 2025 report amounted to DKK -13,201.